Tempus revenue +22% to $382.5M; net income swings positive on $103M equity gains, not operations

Filed July 30, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 8, 2025 · ~2 min read

Key Changes

• high

  Q2 net income of $5.6M (vs. -$42.8M loss prior year) driven by $102.8M gain on Recursion/Personalis equity holdings, while operating loss widened 23% to -$75.9M. Profitability came from below-the-line investment gains, not core business improvement.

  MD&A: Net Income & Operating Loss verify on EDGAR →
• high

  Announced $1.5B Personalis acquisition (all-stock, up to 50% cash option) expected to close late 2026/early 2027, subject to shareholder/regulatory approvals. Deal adds substantial transaction costs, integration risk, and potential shareholder dilution if synergies don't materialize.

  MD&A: Personalis Acquisition; Risk Factors verify on EDGAR →
• high

  Issued $460M convertible notes (0%, 2032 maturity) in May 2026, bringing total convertible debt to $1.21B. Proceeds repaid $318M of term/revolving credit facilities, eliminating secured debt and extending maturity profile but increasing potential equity dilution.

  MD&A: 2032 Notes Issuance verify on EDGAR →